FindTrial
Sign In

Biomarkers in diabetic foot

Serum Biomarkers Procalcitonin and d-dimer in Diabetic Foot

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030653
Enrollment
30
Registered
2021-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E136- Other specified diabetes mellituswith other specified complications

Interventions

None listed

Sponsors

Lady Hardinge Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All new patients of any sex with 18 to 65 years of age with type 2 diabetes mellitus with diabetic foot ulcer in Lady Hardinge Medical College and associated hospitals.

Exclusion criteria

Exclusion criteria: 1) Any patient who has received any antibiotics in last seven days. 2) Patients with other known site of infection.

Design outcomes

Primary

MeasureTime frame
Levels of Biomarkers Procalcitonin and d-dimer among the patients of Diabetic Foot Ulcer Timepoint: Baseline Levels at presentation—

Secondary

MeasureTime frame
Grade of Diabetic Foot Ulcer and itâ??s correlation with Levels of Biomarkers.Timepoint: Baseline At presentation—

Countries

India

Contacts

Public ContactDr Mansi Bansal

Lady Hardinge Medical College

mohtaanup@gmail.com9810478187

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026